Rules of engagement: perspectives on stakeholder engagement for genomic biobanking research in South Africa
Tóm tắt
Genomic biobanking research is undergoing exponential growth in Africa raising a host of legal, ethical and social issues. Given the scientific complexity associated with genomics, there is a growing recognition globally of the importance of science translation and community engagement (CE) for this type of research, as it creates the potential to build relationships, increase trust, improve consent processes and empower local communities. Despite this level of recognition, there is a lack of empirical evidence of the practise and processes for effective CE in genomic biobanking in Africa. To begin to address this vacuum, 17 in-depth face to face interviews were conducted with South African experts in genomic biobanking research and CE to provide insight into the process, benefits and challenges of CE in South Africa. Emerging themes were analysed using a contextualised thematic approach. Several themes emerged concerning the conduct of CE in genomic biobanking research in Africa. Although the literature tends to focus on the local community in CE, respondents in this study described three different layers of stakeholder engagement: community level, peer level and high level. Community level engagement includes potential participants, community advisory boards (CAB) and field workers; peer level engagement includes researchers, biobankers and scientists, while high level engagement includes government officials, funders and policy makers. Although education of each stakeholder layer is important, education of the community layer can be most challenging, due to the complexity of the research and educational levels of stakeholders in this layer. CE is time-consuming and often requires an interdisciplinary research team approach. However careful planning of the engagement strategy, including an understanding of the differing layers of stakeholder engagement, and the specific educational needs at each layer, can help in the development of a relationship based on trust between the research team and various stakeholder groups. Since the community layer often comprises vulnerable populations in low and middle income countries (LMICs), co-development of innovative educational tools on genomic biobanking is essential. CE is clearly a component of a broader process best described as stakeholder engagement.
Tài liệu tham khảo
Abayomi A, Christoffels A, Grewal R, Karam LA, Rossouw C, Staunton C, et al. Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases. Biopreserv Biobank. 2013;11(6):347–54.
Tindana P, de Vries J, Campbell M, Littler K, Seeley J, Marshall P, et al. Community engagement strategies for genomic studies in Africa: a review of the literature. BMC Med. Ethics. 2015;16:24.
Moodley K, Sibanda N, February K, Rossouw T. “It’s my blood”: ethical complexities in the use, storage and export of biological samples: perspectives from south African research participants. BMC Med. Ethics. 2014;15:4.
Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004;189:930–7.
Commission NBA. Ethical and policy issues in international research: clinical trials in developing countries. Rockville, MD: National Bioethics Advisory Commission; 2001.
Moodley K, Singh S. “It’s all about trust”: reflections of researchers on the complexity and controversy surrounding biobanking in South Africa. BMC Med. Ethics. 2016;17:57.
Staunton C, Moodley K. Data mining and biological sample exportation from South Africa: a new wave of bioexploitation under the guise of clinical care? South African Med J. 2016;106:136.
Tindana P, Bull S, Amenga-Etego L, De Vries J, Aborigo R, Koram K, et al. Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience. BMC Med. Ethics. 2012;13:15.
Koen J, Essack Z, Slack C, Lindegger G, Newman PA. “It looks like you just want them when things get rough”: civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials. Dev World Bioeth. 2013;13:138–48.
Macqueen KM, Bhan A, Frohlich J, Holzer J, Sugarman J. Evaluating community engagement in global health research: the need for metrics. BMC Med. Ethics. 2015;16:44.
Marsh V, Kamuya D, Rowa Y, Gikonyo C, Molyneux S. Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust research Programme, Kilifi. Kenya Soc Sci Med. 2008;67:721–33.
Quinn SC. Ethics in public health research: protecting human subjects: the role of community advisory boards. Am J Public Health. 2004;94:918–22.
Tindana PO, Singh JA, Tracy CS, Upshur REG, Daar AS, Singer PA, et al. Grand challenges in Global Health: community engagement in research in developing countries. PLoS Med. 2007;4:e273.
Friedman Ross L, Loup A, Nelson RM, Botkin JR, Kost R, Smith GR Jr, et al. Human subjects protections in community-engaged research: a research ethics framework. J Empir Res Hum Res Ethics. 2010;5(1):5–17.
de Vries J, Bull SJ, Doumbo O, Ibrahim M, Mercereau-Puijalon O, Kwiatkowski D, et al. Ethical issues in human genomics research in developing countries. BMC Med. Ethics. 2011;12:5.
Mwinga A, Moodley K. Engaging with community advisory boards (CABs) in Lusaka Zambia: perspectives from the research team and CAB members. BMC Med. Ethics. 2015;16:39.
Molyneux CS, Wassenaar DR, Peshu N, Marsh K. “Even if they ask you to stand by a tree all day, you will have to do it (laughter) !”: community voices on the notion and practice of informed consent for biomedical research in developing countries. Soc Sci Med. 2005;61:443–54.
Campbell MM, Susser E, De Vries J, Baldinger A, Sibeko G, Mndini MM, et al. Exploring researchers’ experiences of working with a researcher-driven, population-specific community advisory board in a south African schizophrenia genomics study. BMC Med Ethics. 2015;16:45.
Ramsay M, de Vries J, Soodyall H, Norris SA, Sankoh O. H3Africa consortium. Ethical issues in genomic research on the African continent: experiences and challenges to ethics review committees. Hum Genomics. 2014;8:15.
King KF, Kolopack P, Merritt MW, Lavery JV. Community engagement and the human infrastructure of global health research. BMC Med. Ethics. 2014;15:84.
Bowen D, Hyams T, Goodman M, West K, Harris-Wai J, Yu J-H. Systematic review of quantitative measures of stakeholder engagement. Clin Transl Sci. 2017;10(5):314–36.
Garrett SB, Koenig BA, Brown A, Hult JR, Boyd EA, Dry S, et al. EngageUC: developing an efficient and ethical approach to biobanking research at the university of California. Clin. Transl. Sci. 2015;8(4):362–6.
Murphy M, Garrett SB, Boyd E, Dry S, Dohan D. Engaging diverse stakeholders to inform biobank governance. Biopreserv Biobank. 2017;15(4):393–5.
Murtagh MJ, Minion JT, Turner A, Wilson RC, Blell M, Ochieng C, et al. The ECOUTER methodology for stakeholder engagement in translational research. BMC Med Ethics. 2017;18:24.
Munung NS, Mayosi BM, de Vries J. Equity in international health research collaborations in Africa: perceptions and expectations of African researchers. PLoS One. 2017;12(10):e0186237.
Petrini C. ‘Broad’ consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Soc Sci Med. 2010 Jan;70(2):217–20.
Tindana P, de Vries J. Broad consent for genomic research and biobanking: perspectives from low- and middle-income countries. Annu Rev Genomics Hum Genet. 2016;17:375–93.
Caulfield T, Kaye J. Broad consent in biobanking: reflections on seemingly insurmountable dilemmas. Med Law Int. 2009;10:85–100.
Andanda P, Govender S. Regulation of biobanks in South Africa. J Law, Med Ethics. 2015;43(4):787–800.
Tindana P, Campbell M, Marshall P, Littler K, Vincent R, Seeley J, et al. Developing the science and methods of community engagement for genomic research and biobanking in Africa. Glob Heal Epidemiol Genomics. 2017;2:e13. https://doi.org/10.1017/gheg.2017.9.
Marsh VM, Kamuya DK, Parker MJ, Molyneux CS. Working with concepts: the role of Community in International Collaborative Biomedical Research. Public Health Ethics. 2011;4:26–39.
Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS. Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med. Ethics. 2010;11:13.
Molyneux S, Bull S. Consent and community engagement in diverse research contexts: reviewing and developing research and practice. J Empir Res Hum Res Ethics. 2013;8(4):1–18.
Whitworth JAG, Kokwaro G, Kinyanjui S, Snewin VA, Tanner M, Walport M, et al. Strengthening capacity for health research in Africa. Lancet. 2008;372(9649):1590–3.
Masiye F, Mayosi B, de Vries J. “I passed the test!”; evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in cape town, south Africa. BMC Med. Ethics. 2017;18:12.
Wong IY, Lawrence NV, Struthers H, Mcintyre J, Friedland GH. Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. Jaids J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S142–8.
Sanderson SC, Suckiel SA, Zweig M, Bottinger EP, Jabs EW, Richardson LD. Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public. Genet Med. 2016;18(5):501–12.
Munung NS, Marshall P, Campbell M, Littler K, Masiye F, Ouwe-Missi-Oukem-Boyer O, et al. Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents. J Med Ethics. 2016;42(2):132–7.
Biobanking and Beyond - YouTube. Available from: https://www.youtube.com/watch?v=QjSfIA6_bfc&t=7s. Accessed 4 Oct 2016.